| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Corcept Therapeutics Incorporated (NASDAQ: CORT)
CORT Technical Analysis
2
| As on 9th Jun 2023 CORT SHARE Price closed @ 23.32 and we RECOMMEND Sell for LONG-TERM with Stoploss of 23.78 & Strong Buy for SHORT-TERM with Stoploss of 20.09 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CORTSHARE Price
| Open | 23.99 | Change | Price | % |
| High | 24.01 | 1 Day | -0.72 | -3.00 |
| Low | 23.24 | 1 Week | 0.27 | 1.17 |
| Close | 23.32 | 1 Month | 1.09 | 4.90 |
| Volume | 357500 | 1 Year | 2.52 | 12.12 |
| 52 Week High 29.96 | 52 Week Low 16.53 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CORT Daily Charts |
CORT Intraday Charts |
Whats New @ Bazaartrend |
CORT Free Analysis |
|
|
CORT Important Levels Intraday
| RESISTANCE | 24.80 |
| RESISTANCE | 24.33 |
| RESISTANCE | 24.03 |
| RESISTANCE | 23.74 |
| SUPPORT | 22.90 |
| SUPPORT | 22.61 |
| SUPPORT | 22.31 |
| SUPPORT | 21.84 |
CORT Forecast April 2024
| 4th UP Forecast | 36.46 |
| 3rd UP Forecast | 32.25 |
| 2nd UP Forecast | 29.64 |
| 1st UP Forecast | 27.04 |
| 1st DOWN Forecast | 19.6 |
| 2nd DOWN Forecast | 17 |
| 3rd DOWN Forecast | 14.39 |
| 4th DOWN Forecast | 10.18 |
CORT Weekly Forecast
| 4th UP Forecast | 26.44 |
| 3rd UP Forecast | 25.44 |
| 2nd UP Forecast | 24.82 |
| 1st UP Forecast | 24.20 |
| 1st DOWN Forecast | 22.44 |
| 2nd DOWN Forecast | 21.82 |
| 3rd DOWN Forecast | 21.20 |
| 4th DOWN Forecast | 20.20 |
CORT Forecast2024
| 4th UP Forecast | 49.66 |
| 3rd UP Forecast | 41.21 |
| 2nd UP Forecast | 35.99 |
| 1st UP Forecast | 30.77 |
| 1st DOWN Forecast | 15.87 |
| 2nd DOWN Forecast | 10.65 |
| 3rd DOWN Forecast | 5.43 |
| 4th DOWN Forecast | -3.02 |
Corcept Therapeutics Incorporated ( NASDAQ USA Symbol : CORT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CORT Business Profile
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase III clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California. Address: 149 Commonwealth Drive, Menlo Park, CA, United States, 94025
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service